CD44 and neoplasm: Thus, it was shown that the CD44+/c-kit+ population had an approximately 5000-fold increase in tumorigenicity, with tumors forming after the inoculation of as few as 100 cells from primary tumor, xenograft or in vitro-grown spheroid cell population [194].